Klaus Suwelack (Ph.D.) is in New Business Development and Innovation Management at Janssen Germany. His previous position was New Venture Lead Germany for Neuroscience and Digital Health at Johnson & Johnson Innovation, London.

Previously, Klaus was General Manager of the Institute for Innovation and Integration in Healthcare, a newly formed Johnson & Johnson company for psychiatric care management in Germany. Klaus served as Executive Director of Strategic Healthcare Relations at Janssen Germany and he was a Business Unit Director for Neuroscience. He also served as Medical Director and Marketing Director for Desitin GmbH in Hamburg.

Klaus holds a PhD in Pharmacology (University of Bonn) and a Certificate of Business Excellence of Columbia University.